What is the optimal postpartum insulin regimen for a woman with pre‑gestational diabetes mellitus?

Postpartum Insulin Management in Pre-Gestational Diabetes

For women with pre-gestational Type 1 diabetes, immediately resume basal-bolus insulin at 50% of end-of-pregnancy doses (or 80% of pre-pregnancy doses), ensuring basal insulin is NEVER stopped to prevent ketoacidosis; for Type 2 diabetes, continue insulin at 50% of pregnancy doses pending endocrinology consultation. 111

Type 1 Diabetes: Critical Immediate Actions

The postpartum period requires urgent insulin adjustment due to the dramatic drop in insulin resistance after placental delivery. Basal insulin must never be interrupted in Type 1 diabetes—there is a high risk of ketoacidosis even with brief interruptions. 11

Specific Dosing Algorithm for Type 1 Diabetes:

When stopping IV insulin infusion:

• Resume basal insulin immediately if the last subcutaneous dose was >24 hours ago
• Choose ONE of these reduction strategies:
  • 50% of end-of-pregnancy doses (preferred) 111
  • OR 80% of pre-pregnancy doses 11

The rationale: insulin requirements typically double or triple during pregnancy 1, so postpartum needs drop precipitously. Recent research confirms postpartum insulin requirements are approximately 34% lower than preconception doses 2.

For insulin pump users:

• Restart the pump immediately when IV insulin stops 11
• Be aware that automated insulin delivery (AID) systems like Omnipod 5 can take up to 2 weeks to adjust to reduced postpartum needs 3
• Consider proactive strategies: reset the device, increase target glucose to 140 mg/dL, adjust carbohydrate ratios, or temporarily switch to manual mode 3
• Recent data shows auto-basal insulin reduces by only 17.5% immediately postpartum and 31% by 14 days, with manual boluses driving most variation 4

Critical Pitfall to Avoid:

Hypoglycemia is the primary risk postpartum. The 2026 protocol implementation study demonstrated that inadequate dose reduction leads to delayed transfers and hypoglycemic events 5. Patients are autonomous in their diabetes management—involve them in dose adjustments 1.

Type 2 Diabetes: Simplified Approach

Continue insulin at 50% of pregnancy doses while awaiting diabetologist consultation. 111 This is more straightforward than Type 1 diabetes management but still requires significant reduction.

Breastfeeding Considerations:

• Metformin and glyburide can be safely continued during breastfeeding if used successfully during pregnancy 66
• These medications do not require discontinuation for lactation 6

Glycemic Targets Postpartum

Target range: 110-160 mg/dL (6.0-8.8 mmol/L) after vaginal delivery 111

• Slightly lower targets after cesarean section to support wound healing 11
• These are deliberately less strict than pregnancy targets to reduce hypoglycemia risk

Monitoring Protocol

• Continue glucose monitoring before meals and 2 hours postprandially
• Adjust insulin based on actual glucose patterns over first 48-72 hours
• Arrange endocrinology follow-up before hospital discharge 11

Key Distinguishing Feature from Gestational Diabetes

Unlike gestational diabetes (where insulin is completely stopped postpartum 111), pre-gestational diabetes requires continued insulin therapy with dose reduction, not cessation. This distinction is critical for patient safety.

Documentation Requirements

The 2018 Anaesthesia guidelines emphasize creating a written protocol with the diabetologist before delivery, specifying 11:

• Exact basal insulin type and dose
• Rapid-acting analog type and doses
• Pump settings if applicable
• Plan for oral agents if Type 2 diabetes without breastfeeding

This anticipatory planning prevents delays and adverse events in the immediate postpartum period, as confirmed by the 2026 protocol implementation study showing improved efficiency and outcomes 5.